Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,963
Closed -$373K 155
2021
Q3
$373K Buy
4,963
+31
+0.6% +$2.36K 0.01% 138
2021
Q2
$384K Buy
4,932
+602
+14% +$44.8K 0.01% 143
2021
Q1
$319K Buy
4,330
+733
+20% +$54.1K 0.01% 144
2020
Q4
$281K Buy
+3,597
New +$275K 0.01% 147
2015
Q1
Sell
-1,327,757
Closed -$72M 161
2014
Q4
$72M Sell
1,327,757
-475,000
-26% -$26.5M 1.09% 40
2014
Q3
$102M Sell
1,802,757
-873,194
-33% -$49M 1.46% 20
2014
Q2
$148M Buy
2,675,951
+60,747
+2% +$3.31M 2.06% 7
2014
Q1
$142M Sell
2,615,204
-412,220
-14% -$21.3M 2.1% 6
2013
Q4
$145M Buy
3,027,424
+66,050
+2% +$3.02M 2.13% 5
2013
Q3
$135M Sell
2,961,374
-259,570
-8% -$11.9M 2.2% 6
2013
Q2
$143M Buy
+3,220,944
New +$144M 2.3% 5

Other funds holding MRK

Cambiar Investors's MRK Position: Q4 2021 in Review

Cambiar Investors sold out of Merck (MRK) in Q4 2021, closing a stake of 4,963 shares — an estimated $373K sold.

Cambiar Investors first reported a position in MRK in Q2 2013 and held it in 11 quarters. The position peaked at $148M in Q2 2014. 2,902 funds tracked by Wall St. Rank hold MRK as of Q4 2021.

  • Cambiar Investors reported no remaining Merck position as of Q4 2021 after selling out during the quarter.
  • Cambiar Investors sold 4,963 Merck shares in Q4 2021, an estimated $373K.
  • Cambiar Investors first reported a position in Merck in Q2 2013 and held it in 11 quarters.
  • Cambiar Investors's Merck position peaked at $148M in Q2 2014.
  • 2,902 funds tracked by Wall St. Rank held Merck as of Q4 2021.

Based on Cambiar Investors's 13F filing for Q4 2021, filed 27 Jan 2022.